loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 90783 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Teva Pharmaceutical Industries

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 TEVA PHARMS USA (3)

    filter

    01 CAPSULE, DELAYED REL PELLETS;ORAL (3)

    filter

    01 DISCN (3)

    filter

    01 DULOXETINE HYDROCHLORIDE (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DULOXETINE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED R...
    EQ 30MG BASE
    2013-12-11
    90783
    DULOXETINE HYDROCH...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DULOXETINE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED R...
    EQ 60MG BASE
    2013-12-11
    90783
    DULOXETINE HYDROCH...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Israel
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    DULOXETINE HYDROCHLORIDE

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED R...
    EQ 20MG BASE
    2013-12-11
    90783
    DULOXETINE HYDROCH...
    DISCN
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 90783

    Looking for FDA Orange Book APPLICATION 90783 3

    19

    Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DULOXETINE HYDROCHLORIDE, with a corresponding application number 90783.

    Regulatory Information DISCN

    With a dosage strength EQ 30MG BASE

    Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

    Reference Listed Drug No

    Approved since 2013-12-11

    18

    Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DULOXETINE HYDROCHLORIDE, with a corresponding application number 90783.

    Regulatory Information DISCN

    With a dosage strength EQ 60MG BASE

    Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

    Reference Listed Drug No

    Approved since 2013-12-11

    17

    Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is DULOXETINE HYDROCHLORIDE, with a corresponding application number 90783.

    Regulatory Information DISCN

    With a dosage strength EQ 20MG BASE

    Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

    Reference Listed Drug No

    Approved since 2013-12-11

    Post Enquiry
    POST ENQUIRY